Principal Investigator
Bradley Gampel
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250621
Clinical Trial Summary
A Phase 3 Study of Sodium Thiosulfate for Reduction of Cisplatin-Induced Ototoxicity in Children with Average-Risk Medulloblastoma and Reduced Therapy in Children with Medulloblastoma with Low-Risk Features
Phase
Phase III
Funding Agency/Sponsor
National Cooperative Group
Disease
Pediatric Cancer
Contact Information
Phone Number
305-243-2647